Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/S0140-6736(22)01995-X | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Globalisation of antibiotic-resistant bacteria at recurring mass gathering events.
Lancet
July 2023
Department of Infection, Division of Infection and Immunity, University College London, London, UK; NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK.
Mass gatherings medicine: public health issues arising from mass gathering religious and sporting events.
Lancet
May 2019
Division of Infection, University College London, London, UK; NIHR Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address:
Mass gathering events are associated with major public health challenges. The 2014 Lancet Series on the new discipline of mass gatherings medicine was launched at the World Health Assembly of Ministers of Health in Geneva in May, 2014. The Series covered the planning and surveillance systems used to monitor public health risks, public health threats, and experiences of health-care providers from mass gathering events in 2012 and 2013.
View Article and Find Full Text PDFKnowledge and understanding of antibiotic resistance and the risk of becoming a carrier when travelling abroad: a qualitative study of Swedish travellers.
Scand J Public Health
May 2015
Department of Infection Control and Hospital Hygiene, Stockholm County Council, Stockholm, Sweden Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Background: Increasing globalisation, with the migration of people, animals and food across national borders increases the risk of the spread of antibiotic-resistant bacteria. To avoid becoming a carrier of antibiotic-resistant bacteria when travelling, knowledge about antibiotic resistance is important.
Materials And Methods: We aimed to describe the knowledge and understanding of antibiotic-resistant bacteria, and of the risk for becoming a carrier of such bacteria, among Swedish travellers before their travel to high-risk areas.
Use of cytokines in infection.
Expert Opin Emerg Drugs
November 2004
McMaster University, Department of Pathology and Molecular Medicine, Infectious Diseases Division, Centre for Gene Therapeutics, Rm. 4012 - MDCL, 1200 Main Street West, Hamilton, Ontario, Canada L8N 3Z5.
Infectious disease remains an ever-growing health concern worldwide due to increasing antibiotic-resistant microbial strains, immune-compromised populations, international traffic and globalisation, and bioterrorism. There exists an urgent need to develop novel prophylactic and therapeutic strategies. In addition to classic antibiotic therapeutics, immune-modulatory molecules such as cytokines or their inhibitors represent a promising form of antimicrobial therapeutics or immune adjuvant used for the purpose of vaccination.
View Article and Find Full Text PDFThe HIV/AIDS pandemic can truly be described as an infectious disease that has recently emerged and judging from its rapid global spread, it leaves no doubt that it is one of the greatest health threats mankind has to contend with. This pandemic has alerted and stimulated the international scientific community to seriously reflect oa other recent episodes of emerging and re-emerging infections. The examples that have recently been observed and addressed include new emerging infectious diseases, unusual manifestations of previously known diseases and unusual eruption of known diseases in unusual geographic foci or unusual altitudes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!